Human Papillomavirus Information - October 13, 2008

EU Approves Cervical Cancer Vaccine

September 22, 2006 - Topics vaccine, cancer, cervical cancer, hpv and women
The European Union has endorsed a cervical cancer vaccine called Gardasil. British medical doctors say the vaccine could prevent about 3,000 cancers annually in the UK alone.

The vaccine will be administered to girls and women aged from nine to twenty-six. The Sanofi Pasteur-made vaccine works against human papillomavirus (HPV), which is said to cause cervical cancer, and also protects against cervical cancer caused by HPV strains 6, 11, 16 and 18

read more >>

HPV Could Interfere With In Vitro Fertilization

September 20, 2006 - Topics hpv, women, sex, study and genital
A new study suggests that Human papillomavirus (HPV) may make it more difficult to conceive with in vitro fertilization (IVF). The study that was published in the journal Fertility and Sterility, only 17 women in the group of more than 100 tested positive for HPV.

The ABC news reports that researchers from New York Hospital-Cornell Medical Center found that women who tested positive for HPV were about half as likely to conceive from IVF compared to women who tested negative

read more >>

Leading Women's Group Calls For Mandatory Middle School HPV Vaccination

September 12, 2006 - Topics hpv, women, vaccination, disease and cancer
A national, bi-partisan, non-profit organization is calling on middle schools to make vaccination against the human papillomavirus (HPV), mandatory for girls.

HPV is the cause of cervical cancer, and now the group, Women In Government, which represents women state legislators, says all girls should take the Food and Drug Administration (FDA) approved vaccine

read more >>

Vaccine Could Cut Cervical Cancer Deaths By 75 Pct

September 4, 2006 - Topics vaccine, cervical cancer, cancer, human papillomavirus and hpv
A study presented at the International Papillomavirus Conference in Prague, Monday, suggests that vaccinating all girls under 12 against the virus responsible for causing the cervical cancer, could cut the number of disease related deaths by 75 percent. Drug maker GlaxoSmithKline' said its experimental vaccine Cervarix prevents infection from two strains of the human papillomavirus (HPV) which account for about 70 percent of cases of cervical cancer.

In a computer model study sponsored by GlaxoSmithKline, the researchers predicted the impact the vaccine would have in Britain if all 12 year-old girls were vaccinated. Although researchers acknowledged that the 100 percent coverage assumed in the study was unrealistic, but asserted that even if 80 percent of the teens were vaccinated it could reduce the cervical cancer cases and related deaths by 61 percent

read more >>

South Australian Woman Given First Cancer Vaccine

August 28, 2006 - Topics cancer, australia, vaccine, human papillomavirus and hpv
The world's first vaccine against cervical cancer was given to a woman in South Australia on Monday.

Gardasil, the first anti-cancer vaccine was approved by the Therapeutic Goods Administration to be used on girls from the age of nine to 26 and boys aged from nine to 15

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use